Found: 28
Select item for more details and to access through your institution.
Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment.
- Published in:
- International Journal of Bipolar Disorders, 2017, v. 5, n. 1, p. 1, doi. 10.1186/s40345-017-0075-7
- By:
- Publication type:
- Article
The direct and indirect effects of lurasidone monotherapy on functional improvement among patients with bipolar depression: results from a randomized placebo-controlled trial.
- Published in:
- International Journal of Bipolar Disorders, 2016, v. 4, n. 1, p. 1, doi. 10.1186/s40345-016-0049-1
- By:
- Publication type:
- Article
Comparative Utility of Aripiprazole and Haloperidol in Schizophrenia.
- Published in:
- Applied Health Economics & Health Policy, 2009, v. 7, n. 2, p. 109, doi. 10.1007/BF03256145
- By:
- Publication type:
- Article
Short-term efficacy and safety of lurasidone versus placebo in antipsychotic-naïve versus previously treated adolescents with an acute exacerbation of schizophrenia.
- Published in:
- European Psychiatry, 2022, v. 65, n. 1, p. 1, doi. 10.1192/j.eurpsy.2022.11
- By:
- Publication type:
- Article
Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: A pooled post hoc analysis of double-blind, placebocontrolled 6-week studies.
- Published in:
- European Psychiatry, 2021, v. 64, n. 1, p. 1, doi. 10.1192/j.eurpsy.2021.30
- By:
- Publication type:
- Article
Implementing Digital Technologies in Clinical Trials: Lessons Learned.
- Published in:
- Innovations in Clinical Neuroscience, 2022, v. 19, n. 4-6, p. 65
- By:
- Publication type:
- Article
Personalized treatment with atypical antipsychotic medications.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Personalized treatment with atypical antipsychotic medications.
- Published in:
- Advances in Therapy, 2007, v. 24, n. 4, p. 721, doi. 10.1007/BF02849966
- By:
- Publication type:
- Article
Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophrenia.
- Published in:
- BMC Psychiatry, 2016, v. 16, p. 1, doi. 10.1186/s12888-016-0879-5
- By:
- Publication type:
- Article
Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials.
- Published in:
- BMC Psychiatry, 2016, v. 16, p. 1, doi. 10.1186/s12888-016-0865-y
- By:
- Publication type:
- Article
The development of lurasidone for bipolar depression.
- Published in:
- Annals of the New York Academy of Sciences, 2015, v. 1358, n. 1, p. 95, doi. 10.1111/nyas.12965
- By:
- Publication type:
- Article
Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.
- Published in:
- BMC Psychiatry, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-244X-14-53
- By:
- Publication type:
- Article
One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis.
- Published in:
- BMC Psychiatry, 2011, v. 11, n. 1, p. 6, doi. 10.1186/1471-244X-11-6
- By:
- Publication type:
- Article
A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials.
- Published in:
- Journal of Psychopharmacology, 2010, v. 24, n. 7, p. 1019, doi. 10.1177/0269881109348157
- By:
- Publication type:
- Article
A Systematic Review of Augmentation Strategies for Patients with Major Depressive Disorder.
- Published in:
- Psychopharmacology Bulletin, 2009, v. 42, n. 3, p. 57
- By:
- Publication type:
- Article
Atypical Antipsychotic Drugs and Diabetes Mellitus in the US Food and Drug Administration Adverse Event Database: A Systematic Bayesian Signal Detection Analysis.
- Published in:
- Psychopharmacology Bulletin, 2009, v. 42, n. 1, p. 11
- By:
- Publication type:
- Article
Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010).
- Published in:
- Psychopharmacology Bulletin, 2008, v. 41, n. 2, p. 12
- By:
- Publication type:
- Article
IS METABOLIC SYNDROME RELATED TO COGNITIVE PERFORMANCE IN PATIENTS WITH SCHIZOPHRENIA? RESULTS FROM A DOUBLE-BLIND, ACTIVE-CONTROLLED, LURASIDONE STUDY.
- Published in:
- Schizophrenia Bulletin, 2020, v. 46, p. S152, doi. 10.1093/schbul/sbaa030.360
- By:
- Publication type:
- Article
BENEFITS AND HARMS OF ANTIPSYCHOTICS IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH SCHIZOPHRENIA: AÂ SYSTEMATIC REVIEW AND META-ANALYSIS.
- Published in:
- Schizophrenia Bulletin, 2020, v. 46, p. S242, doi. 10.1093/schbul/sbaa029.588
- By:
- Publication type:
- Article
DOES THE TIME OF DRUG ADMINISTRATION ALTER THE ADVERSE EVENT RISK OF LURASIDONE?
- Published in:
- Schizophrenia Bulletin, 2020, v. 46, p. S31, doi. 10.1093/schbul/sbaa031.071
- By:
- Publication type:
- Article
S3. THE ADVERSE EFFECT OF 10 ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA ON GLUCOSE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF PLACEBO-CONTROLLED TRIALS.
- Published in:
- Schizophrenia Bulletin, 2019, v. 45, p. S306, doi. 10.1093/schbul/sbz020.548
- By:
- Publication type:
- Article
F106. EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAïVE ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 6-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY.
- Published in:
- Schizophrenia Bulletin, 2019, v. 45, p. S293, doi. 10.1093/schbul/sbz018.518
- By:
- Publication type:
- Article
F26. C-REACTIVE PROTEIN AND RESPONSE TO LURASIDONE TREATMENT IN ADOLESCENTS WITH SCHIZOPHRENIA.
- Published in:
- Schizophrenia Bulletin, 2019, v. 45, p. S264, doi. 10.1093/schbul/sbz018.438
- By:
- Publication type:
- Article
F4. THE EFFECT OF ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA ON LIPID PARAMETERS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF PLACEBO-CONTROLLED TRIALS.
- Published in:
- Schizophrenia Bulletin, 2019, v. 45, p. S256, doi. 10.1093/schbul/sbz018.416
- By:
- Publication type:
- Article
Short-term physical compatibility of intramuscular aripiprazole with intramuscular lorazepam.
- Published in:
- American Journal of Health-System Pharmacy, 2008, v. 65, n. 21, p. 2007, doi. 10.2146/ajhp070067
- By:
- Publication type:
- Article
Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study.
- Published in:
- BMC Psychiatry, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12888-020-02523-1
- By:
- Publication type:
- Article
Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US.
- Published in:
- ClinicoEconomics & Outcomes Research, 2013, v. 5, p. 459, doi. 10.2147/CEOR.S47990
- By:
- Publication type:
- Article